Wall Street ReporterNEW YORK, June 29, 2021 (GLOBE NEWSWIRE) -- Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: WELL Health Technologies (TSX: WELL) (OTC: WLYYF), AI/ML Innovations (OTC: AIMLF) (CSE: AIML), Reliq Health Technologies (OTC: RQHTF) (TSX.V: RHT) and CloudMD (OTC: DOCRF) (TSX.V: DOC) WELL Health Technologies (TSX: WELL) (OTC: WLYYF) “The ‘Berkshire Hathaway’ of Tech-Enabled Health Care - On Track to $400 Million Revenues”
“...We regard ourselves, aspirationally, as the Berkshire Hathaway tech-enabled health care. Much like Berkshire Hathaway, our goal is to make investments in highly successful and resilient companies run by top-notch management teams that have a superior track record of delivering results. The main difference here is that Berkshire, has a very wide mandate and ours is very much focused on the theme of tech-enabled healthcare, as we see this as a pivotal time, where digitization and modernization are occurring in one of the largest sectors in the world….”
“...Furthermore, Berkshire Hathaway companies and leaders are invited to stay, be empowered and continue their journey while benefiting from being in the group. We have similarly structured the company into several business units, each with its own business unit leader. WELL is employing a decentralized operating strategy where most of the operating decisions are managed by the leaders of the different business units. This allows the company to grow in scale without added bureaucracy, and leaner shared services.
“... WELL’s goals for 2021: One, is to drive organic growth across all our business units and again, using the opportunity to cross-fertilize and leverage new opportunities through the network effects brought about by our growing network. Two, continue to follow a very disciplined acquisition and capital allocation strategy. Three, increase EBITDA throughout the year. Four, increase operating cash flows through acquisitions, optimizing costs and digitizing clinical assets. And five, increasing our market share of digital health and virtual care-related products and programs.
“Our outlook remains very positive across all our business units. We continue to have approximately 9 executed LOIs signed and pending for execution. The value of these LOIs when combined with our existing deals propels us to well over $400 million in revenue and over $100 million in EBITDA. Given the strong scale, WELL continues to seriously evaluate the prospects and feasibility of a U.S. IPO in the next few months….” WELL Health Technologies Corp. (TSX: WELL) (OTC: WLYYF) Earnings Highlights: https://bit.ly/3604nnc